These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
172 related articles for article (PubMed ID: 15911336)
21. Asthma and poly(ADP-ribose) polymerase inhibition: a new therapeutic approach. Zaffini R; Gotte G; Menegazzi M Drug Des Devel Ther; 2018; 12():281-293. PubMed ID: 29483769 [TBL] [Abstract][Full Text] [Related]
22. Role of free radicals and poly(ADP-ribose)polymerase-1 in the development of spinal cord injury: new potential therapeutic targets. Genovese T; Cuzzocrea S Curr Med Chem; 2008; 15(5):477-87. PubMed ID: 18289003 [TBL] [Abstract][Full Text] [Related]
23. A novel and potent poly(ADP-ribose) polymerase-1 inhibitor, FR247304 (5-chloro-2-[3-(4-phenyl-3,6-dihydro-1(2H)-pyridinyl)propyl]-4(3H)-quinazolinone), attenuates neuronal damage in in vitro and in vivo models of cerebral ischemia. Iwashita A; Tojo N; Matsuura S; Yamazaki S; Kamijo K; Ishida J; Yamamoto H; Hattori K; Matsuoka N; Mutoh S J Pharmacol Exp Ther; 2004 Aug; 310(2):425-36. PubMed ID: 15075382 [TBL] [Abstract][Full Text] [Related]
24. Modulation of transcription by PARP-1: consequences in carcinogenesis and inflammation. Aguilar-Quesada R; Muñoz-Gámez JA; Martín-Oliva D; Peralta-Leal A; Quiles-Pérez R; Rodríguez-Vargas JM; Ruiz de Almodóvar M; Conde C; Ruiz-Extremera A; Oliver FJ Curr Med Chem; 2007; 14(11):1179-87. PubMed ID: 17504138 [TBL] [Abstract][Full Text] [Related]
25. Effects of poly(ADP-ribose) polymerase inhibition on inflammatory cell migration in a murine model of asthma. Virág L; Bai P; Bak I; Pacher P; Mabley JG; Liaudet L; Bakondi E; Gergely P; Kollai M; Szabó C Med Sci Monit; 2004 Mar; 10(3):BR77-83. PubMed ID: 14976461 [TBL] [Abstract][Full Text] [Related]
26. Increased poly(ADP-ribosyl)ation in peripheral leukocytes and the reperfused myocardium tissue of rats with ischemia/reperfusion injury: prevention by 3-aminobenzamide treatment. Zhang LQ; Qi GX; Jiang DM; Tian W; Zou JL Shock; 2012 May; 37(5):492-500. PubMed ID: 22266967 [TBL] [Abstract][Full Text] [Related]
27. Importance of poly(ADP-ribose) glycohydrolase in the control of poly(ADP-ribose) metabolism. Davidovic L; Vodenicharov M; Affar EB; Poirier GG Exp Cell Res; 2001 Aug; 268(1):7-13. PubMed ID: 11461113 [TBL] [Abstract][Full Text] [Related]
28. Activation of poly(ADP-ribose) polymerase in circulating leukocytes during myocardial infarction. Murthy KG; Xiao CY; Mabley JG; Chen M; Szabó C Shock; 2004 Mar; 21(3):230-4. PubMed ID: 14770035 [TBL] [Abstract][Full Text] [Related]
29. Silencing of poly(ADP-ribose) polymerase-1 suppresses hyperstretch-induced expression of inflammatory cytokines in vitro. Wang J; Liu L; Xia Y; Wu D Acta Biochim Biophys Sin (Shanghai); 2014 Jul; 46(7):556-64. PubMed ID: 24829399 [TBL] [Abstract][Full Text] [Related]
34. Poly(ADP-ribosyl)ation enzyme-1 as a target for neuroprotection in acute central nervous system injury. Skaper SD Curr Drug Targets CNS Neurol Disord; 2003 Oct; 2(5):279-91. PubMed ID: 14529360 [TBL] [Abstract][Full Text] [Related]
35. Poly(ADP-ribosyl)ation inhibitors: promising drug candidates for a wide variety of pathophysiologic conditions. Beneke S; Diefenbach J; Bürkle A Int J Cancer; 2004 Oct; 111(6):813-8. PubMed ID: 15300792 [TBL] [Abstract][Full Text] [Related]